A MULTICENTER, RANDOMIZED, OPEN-LABEL, PARALLEL GROUP PILOT STUDY TO EVALUATE SAFETY AND EFFICACY OF CONVALESCENT METHYLENE BLUE TREATED (MBT) PLASMA FROM DONORS RECOVERED FROM CORONAVIRUS DISEASE 2019 (COVID-19) WITH STANDARD MEDICAL TREATMENT (SMT) VERSUS SMT ALONE IN SUBJECTS WITH COVID-19 REQUIRING ADMISSION TO THE INTENSIVE CARE UNIT (ICU) ' - GC2003


Tabla resumen
 Institución: URV Tipo: Transferencia
 Ámbito: Europeo Duración: 22/09/2020 - 23/09/2021
 Miembros: 4 IP: Mujer
 Fondos: 195950,00 Descripción: Europeo